Review of AHA scientific statement on pharmacological management of cardiac arrhythmias in the fetal and neonatal periods

This scientific statement (1) provides an overview of the main provisions of American Heart Association for management of cardiac arrhythmias in the fetal and neonatal periods.Authors discuss the mechanism of arrhythmias, pharmacological treatment options, and distinct aspects of pharmacokinetics for the fetus and neonate.It is noted that although there has been an improvement in non-invasive diagnosis of fetal and newborns arrhythmias, there are no evidence-based recommendations for the pharmacological management of these disorders, as well as future directions for research are presented.